Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis:A Real-World Prospective Cohort Study. | MicrobiomeTrials← Back to trialsNCT07726888
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis:A Real-World Prospective Cohort Study.
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2028-12-31
Enrollment target: 97 participants Locations- The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Other microbiome trials you might be interested in
Ulcerative Colitis
The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-a…
New York, United StatesEst. completion Jun 23, 2027
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Recruiting
Ulcerative ColitisCrohn's Disease
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (C…
Cambridge, United StatesEst. completion Dec 15, 2026